Deutsche Bank downgrades Select Medical stock on acquisition agreement
#Deutsche Bank #Select Medical #Stock Downgrade #Acquisition Agreement #Price Target #Buyout Premium #Analyst Ratings #SEM Stock
📌 Key Takeaways
- Deutsche Bank downgraded Select Medical stock to Hold after acquisition announcement
- The acquisition offers $16.50 per share, representing an 18% premium over recent prices
- Select Medical shares have risen significantly since the acquisition proposal was announced
- Analysts have mixed views on the acquisition, with Mizuho maintaining Outperform and RBC Capital downgrading to Sector Perform
📖 Full Retelling
Deutsche Bank downgraded Select Medical Holdings (NYSE:SEM) stock from Buy to Hold on Monday, raising its price target to $16.50 from $16.20 following the company's entry into a definitive acquisition agreement with a consortium led by its Executive Chairman Robert A. Ortenzio and Senior Executive Vice President Martin F. Jackson. The downgrade comes as Select Medical shares have surged 16% since November 24, 2025, the day before the initial take-private proposal was announced, representing a 68% annualized gain through March 3. Currently trading at $16.26 with a market cap of $2.1 billion, the stock has delivered a 9.6% return over the past week and 26% over six months, according to Deutsche Bank analyst Justin Bowers, who cited the stock's recent performance as a key factor in the rating change. The acquisition agreement will see the consortium acquire all outstanding shares not already owned by the group for $16.50 per share in cash, representing an enterprise value of $3.9 billion and offering an 18% premium over the share price on November 24, 2025, and a 25% premium over the 90-day volume-weighted average closing share price.
🏷️ Themes
Stock Ratings, Corporate Acquisitions, Market Performance
📚 Related People & Topics
Deutsche Bank
German banking and financial services company
Deutsche Bank AG (German pronunciation: [ˈdɔʏtʃə ˈbaŋk ʔaːˈɡeː] , lit. 'German Bank') is a German multinational investment bank and financial services company headquartered in Frankfurt. It is dual-listed on the Frankfurt Stock Exchange and the New York Stock Exchange. Deutsche Bank was founded in ...
Select Medical
American healthcare company
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
Entity Intersection Graph
Connections for Deutsche Bank:
🌐
Middle East
2 shared
🏢
Banca Monte dei Paschi di Siena
1 shared
🏢
BNP Paribas
1 shared
🏢
Citigroup
1 shared
🌐
Valuation
1 shared
Mentioned Entities
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Oil prices surge higher as conflict threatens supply; Goldman lifts forecasts South Korean stock trading temporarily halted as KOSPI slides over 11% Goldman lifts oil price forecast amid Hormuz disruptions, lower inventories Stocks close in the red as widening Middle East conflict sparks inflation fears (South Africa Philippines Nigeria) Deutsche Bank downgrades Select Medical stock on acquisition agreement By Analyst Ratings Published 03/04/2026, 04:01 AM Deutsche Bank downgrades Select Medical stock on acquisition agreement 0 SEM 8.40% Investing.com - Deutsche Bank downgraded Select Medical Holdings (NYSE:SEM) to Hold from Buy on Monday, raising its price target to $16.50 from $16.20. The downgrade follows Select Medical entering a definitive agreement to be acquired. Analyst Justin Bowers cited the stock’s recent performance as a factor in the rating change. Select Medical shares have risen 16% since the November 24, 2025 closing price, the day before the initial take-private proposal was announced. This represents a 68% annualized gain through the March 3 close. The stock, currently trading at $16.26 with a market cap of $2.1 billion, has delivered a 9.6% return over the past week and 26% over six months. According to InvestingPro analysis, the company remains undervalued based on its Fair Value assessment, with analysts recently revising earnings estimates upward. Investors can access 4 additional InvestingPro Tips and a comprehensive Pro Research Report for deeper insights into SEM’s acquisition potential. Shareholders who retained ownership of both Select Medical and Concentra have generated a 69% return to date. This return is measured against Select Medical’s pre-spin valuation on January 3, 2024. January 3, 2024 marked the day before Select Medical announced its intent to spin off Concentra, which Deutsche Bank identified as the beginning of its Value with a Catalyst series. In other recent news, Se...
Read full article at source